rs587777770
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_006623.4(PHGDH):c.418G>A(p.Gly140Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,120 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006623.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251474Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135906
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461120Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 726942
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
PHGDH deficiency Pathogenic:2Uncertain:1
- -
Variant summary: PHGDH c.418G>A (p.Gly140Arg) results in a non-conservative amino acid change located in the D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain (IPR006140) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251474 control chromosomes. c.418G>A has been reported in the literature in multiple homozygous individuals affected with clinical features of Phosphoglycerate Dehydrogenase Deficiency (Shaheen_2014, El-Hattab_2016). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26960553, 24836451, 30214071). ClinVar contains an entry for this variant (Variation ID: 139534). Based on the evidence outlined above, the variant was classified as pathogenic. -
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 140 of the PHGDH protein (p.Gly140Arg). This variant is present in population databases (rs587777770, gnomAD 0.007%). This missense change has been observed in individual(s) with Neu-Laxova syndrome (PMID: 24836451, 26960553). ClinVar contains an entry for this variant (Variation ID: 139534). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). -
Neu-Laxova syndrome 1 Pathogenic:1
- -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at